Home › Lab Tests › 17-Hydroxyprogesterone (17-OHP) – Newborn Screening
₹599₹960 38% off
The 17-Hydroxyprogesterone (17-OHP) Newborn Screening test measures the level of 17-hydroxyprogesterone in a newborn baby's blood.
It is primarily used to screen for congenital adrenal hyperplasia (CAH), particularly 21-hydroxylase deficiency, an inherited condition affecting adrenal hormone production.
Early screening helps identify babies who may need further medical evaluation and treatment. An abnormal screening result does not confirm the condition and requires appropriate confirmatory testing.
No fasting is required.
Sample is collected using a heel-prick technique.
Preferably collect after 24 hours of birth.
Apply blood drops to the designated newborn screening filter paper.
Ensure blood spots are properly saturated.
Allow the filter paper to dry completely.
Avoid contamination and moisture exposure.
Provide baby's date of birth, birth weight and gestational age.
Inform the laboratory if the baby is premature or has low birth weight.
Follow the performing laboratory's sample transportation instructions.